PIK3CA and esophageal cancer: The MTT (Figure 6A) and colony-formation assays (Figure 6B) data showed that PI3K/AKT inhibition significantly increased the sensitivity of esophageal cancer cell lines to 5-FU and cisplatin (DDP).